Sensitive nanowire disease detectors made by Yale scientists

October 13, 2008

New Haven, Conn. - Yale scientists have created nanowire sensors coupled with simple microprocessor electronics that are both sensitive and specific enough to be used for point-of-care (POC) disease detection, according to a report in Nano Letters.

The sensors use activation of immune cells by highly specific antigens - signatures of bacteria, viruses or cancer cells - as the detector. When T cells are activated, they produce acid, and generate a tiny current in the nanowire electronics, signaling the presence of a specific antigen. The system can detect as few as 200 activated cells.

In earlier studies, these researchers demonstrated that the nanowires could detect generalized activation of this small number of T cells. The new report expands that work and shows the nanowires can identify activation from a single specific antigen even when there is substantial background "noise" from a general immune stimulation of other cells.

Describing the sensitivity of the system, senior author Tarek Fahmy, Yale assistant professor of biomedical engineering, said:. "Imagine I am the detector in a room where thousands of unrelated people are talking - and I whisper, 'Who knows me?' I am so sensitive that I can hear even a few people saying, 'I do' above the crowd noise. In the past, we could detect everyone talking - now we can hear the few above the many."

According to the authors, this level of sensitivity and specificity is unprecedented in a system that uses no dyes or radioactivity. Beyond its sensitivity, they say, the beauty of this detection system is in its speed - producing results in seconds - and its compatibility with existing CMOS electronics.

"We simply took direction from Mother Nature and used the exquisitely sensitive and flexible detection of the immune system as the detector, and a basic physiological response of immune cells as the reporter," said postdoctoral fellow and lead author, Eric Stern. "We coupled that with existing CMOS electronics to make it easily usable."

The authors see a huge potential for the system in POC diagnostic centers in the US and in underdeveloped countries where healthcare facilities and clinics are lacking. He says it could be as simple as an iPod-like device with changeable cards to detect or diagnose disease. Importantly, Stern notes that the system produces no false positives - a necessity for POC testing.

The authors suggest that in a clinic, assays could immediately determine which strain of flu a patient has, whether or not there is an HIV infection, or what strain of tuberculosis or coli bacteria is present. Currently, there are no electronic POC diagnostic devices available for disease detection. "Instruments this sensitive could also play a role in detection of residual disease after antiviral treatments or chemotherapy," said Fahmy. "They will help with one of the greatest challenges we face in treatment of disease - knowing if we got rid of all of it."

Yale University

---

---

	THE URGENT CALL OF ALBUMINURIA/PROTEINURIA: Heeding its significance in early detection of kidney disease Proteinuria is often the first evidence of progressive ... care physicians. (Postgraduate Medicine) by JTE Multimedia The importance of early detection of and intervention in kidney disease cannot be understated. Studies demonstrate that if renoprotective therapies are initiated early, a patient can live a normal life span without developing end-stage renal disease (ESRD). Consequently, proteinuria, which typically serves as the first evidence of progressive kidney disease, demands the understanding and attention of primary care physicians. In this article, Drs Hebert, Spetie, and Keane review the mechanisms, testing methods, and clinical significance of proteinuria. Management of proteinuric patients with renal disease or at risk for cardiovascular disease is also explored. Original Publication Date: October 2001
	Drug-Induced Diseases: Prevention, Detection, and Management, 2nd Edition by Dr. James E. Tisdale PharmD BCPS FCCP (Editor), Douglas A Miller Pharm.D. (Editor) A drug-induced disease is the unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result of morbidity and/or mortality associated with drug-induced diseases. Despite best efforts to assure that all drugs are safe and effective, millions of patients each year develop drug-induced diseases. Every time a patient presents with a new disease or an exacerbation of an existing condition, the clinician should ask, Could this be drug-related?A" Now in its second edition, this essential and comprehensive resource provides a detailed analysis of...
	UPDATE ON ALZHEIMER'S DISEASE: Promising advances in detection and treatment (Postgraduate Medicine) by JTE Multimedia Alzheimer's disease is the most common cause of dementia in the United States. Distinguishing this disease from other types of dementia can be difficult, but there are numerous findings on history taking and physical examination that can help improve diagnostic accuracy. The authors discuss advances in the understanding of disease pathogenesis as well as in pharmacologic therapies, including potential disease-modifying agents. Original Publication Date: October 1999
	CHRONIC OBSTRUCTIVE PULMONARY DISEASE: Prevention, early detection, and aggressive treatment can make a difference (Postgraduate Medicine) by JTE Multimedia Chronic obstructive pulmonary disease has traditionally been considered incurable and progressive. However, new treatment options may improve quality of life and extend survival. In this article, Drs Fraser and Chapman offer guidelines for accurate and early diagnosis and describe the latest treatment options to alleviate symptoms, help with smoking cessation, and increase survival rates. Fraser KL, Chapman KR. Chronic obstructive pulmonary disease: prevention, early detection, and aggressive treatment can make a difference. Original Publication Date: December 2000
	Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis by Jeffrey Burns (Author), John Morris (Author) Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease.Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology and...
	Microbial Plant Pathogens-Detection and Disease Diagnosis:: Fungal Pathogens, Vol.1 by P. Narayanasamy (Author) Morphological, biological, biochemical and physiological characteristics have been used for the detection, identification and differentiation of fungal pathogens up to species level. Tests based on biological characteristics are less consistent. Immunoassays have been shown to be effective in detecting fungal pathogens present in plants and environmental samples. Development of monoclonal antibody technology has greatly enhanced the sensitivity and specificity of detection, identification and differentiation of fungal species and varieties/strains. Nucleic acid-based techniques involving hybridization with or amplification of unique DNA have provided results rapidly and reliably. Presentation of a large number of protocols is a unique feature of this volume.
	Microbial Plant Pathogens-Detection and Disease Diagnosis:: Bacterial and Phytoplasmal Pathogens, Vol.2 by P. Narayanasamy (Author) Microbial plant pathogens causing qualitative and quantitative losses in all corps are present not only in the infected plants, but also in the environmental comprising of soil, water and air. The vectors present in the environment spread the microbial pathogens to short and/or long distances. Detection of microbial pathogens rapidly and reliably by employing suitable sensitive applicable for different ecosystems. The pathogens have to be identified precisely and differentiated and quantified to plan appropriate short- and long-term strategies to contain the incidence and spread of diseases induced by them. This book aims to present all relevant and latest information on the detection techniques based on the biological, biochemical, immunological and nucleic acid characteristics of...
	Global Infectious Disease Surveillance and Detection: Assessing the Challenges -- Finding Solutions, Workshop Summary by Forum on Microbial Threats (Editor), Stanley M. Lemon (Editor), Margaret A. Hamburg (Editor), P. Frederick Sparling (Editor), Eileen R. Choffnes (Editor), Alison Mack (Editor)
	Plant Pathogen-Detection & Disease Diagnosis Revised & Expanded (Books in Soils, Plants, and the Environment) by P. Narayanasamy (Author) This work provides information on the detection, identification, and differentiation of all microbial plant pathogens - presenting modern protocols for rapid diagnosis of diseases based on biological, physical, chemical and molecular properties. It contains methods for the selection of disease-free seeds and vegetatively propagated planting materials and quarantine techniques for screening newly introduced plant materials.
	The Healthy House Plant: A Guide to the Prevention, Detection, and Cure of Pests and Diseases by Jean F. Blashfield (Author) A guide to the prevention, detection and cure of pests and diseases.